Moderna posts a promising snapshot of human data for a leading Covid-19 vaccine — and rally makes Bob Langer a billionaire
Moderna $MRNA just posted some of the most eagerly anticipated human data for a vaccine in modern history. And it’s positive.
The bottom line: Moderna’s mRNA-1273 triggered a therapeutic immune response in 8 patients at the low and mid-dose — 25 μg and 100 μg after a single injection. There were dose-dependent increases in immunogenicity through both doses covering 4 patients in each group, according to Moderna, with patients achieving the same or better level of response seen in recovering patients.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 86,500+ biopharma pros reading Endpoints daily — and it's free.